Vaccine Development

Sep 16, 2015
By BioPharm International Editors
Novovax’s investigational vaccine targeting respiratory syncytial virus (RSV) demonstrated clinical effectiveness in animal models.
Aug 13, 2015
By BioPharm International Editors
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.
Jul 24, 2015
By BioPharm International Editors
GSK’s malaria candidate vaccine for the prevention of malaria in young children received a positive opinion from EMA.
Jul 16, 2015
By BioPharm International Editors
GSK accelerates delivery timeline for US quadrivalent flu vaccine.
Jul 13, 2015
By BioPharm International Editors
The European Medicines Agency reviews the safety of human papillomavirus vaccines.
Jul 07, 2015
By BioPharm International Editors
The European Pharmacopoeia has incorporated new provisions to encourage the use of in-process quality control methods.
Jun 25, 2015
By BioPharm International Editors
IDT Biologika acquired Aeras' vaccine manufacturing facility, and the companies will work together on tuberculosis vaccine development.
Jun 25, 2015
By BioPharm International Editors
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
May 21, 2015
By BioPharm International Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
By BioPharm International Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
native1_300x100
lorem ipsum